• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌患者的肠道微生物群可增强 Apc 小鼠肠道腺瘤的进展。

Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apc mice.

机构信息

Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin, China.

Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin, China; Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

EBioMedicine. 2019 Oct;48:301-315. doi: 10.1016/j.ebiom.2019.09.021. Epub 2019 Oct 5.

DOI:10.1016/j.ebiom.2019.09.021
PMID:31594750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6838415/
Abstract

BACKGROUND

Accumulating evidence points to a close relationship between gut dysbiosis and colorectal cancer (CRC). As >90% of CRC develop from adenoma, we aimed to investigate the crucial role of imbalanced gut microbiota on the progression of intestinal adenoma.

METHODS

The Apc mice gavage with phosphate-buffered saline (PBS), feces from healthy controls or CRC patients after antibiotic cocktails. The intestinal tissues were isolated for histopathology, western blotting, and RNA-seq. The microbiota of feces and short-chain fatty acids (SCFAs) were analysed by 16S rDNA Amplicon Sequencing and gas chromatography.

FINDINGS

The Apcmice gavaged by feces from CRC patients had more intestinal tumours compared with those fed with feces from healthy controls or PBS. Administration of feces from CRC patients increased tumour proliferation and decreased apoptosis in tumour cells, accompanied by impairment of gut barrier function and up-regulation the pro-inflammatory cytokines profile. The up-regulated the expression of β-catenin and cyclinD1 further indicating the activation of Wnt signalling pathway. The abundance of pathogenic bacteria was increased after FMT, while producing SCFAs bacteria and SCFAs production were decreased.

INTERPRETATION

Gut microbiota of CRC patients disrupted intestinal barrier, induced low-grade inflammation and dysbiosis. The altered gut microbiota enhanced the progression of intestinal adenomas in Apcmice, suggesting that a new strategy to target gut microbiota against CRC could be noted. FUND: The study was supported by the National Natural Science Foundation of China, Tianjin Research Programme of Application Foundation and Advanced Technology of China, and China Postdoctoral Science Foundation.

摘要

背景

越来越多的证据表明肠道菌群失调与结直肠癌(CRC)密切相关。由于>90%的 CRC 由腺瘤发展而来,我们旨在研究肠道微生物群落失衡在肠腺瘤进展中的关键作用。

方法

用抗生素鸡尾酒处理 Apc 小鼠,然后用磷酸盐缓冲盐水(PBS)、健康对照者或 CRC 患者的粪便灌胃。分离肠组织进行组织病理学、western blot 和 RNA-seq 分析。通过 16S rDNA 扩增子测序和气相色谱分析粪便和短链脂肪酸(SCFA)的微生物群。

结果

与用健康对照者粪便或 PBS 灌胃的 Apc 小鼠相比,用 CRC 患者粪便灌胃的 Apc 小鼠有更多的肠道肿瘤。CRC 患者粪便的给予增加了肿瘤细胞的增殖和减少了凋亡,同时损害了肠道屏障功能并上调了促炎细胞因子谱。β-连环蛋白和细胞周期蛋白 D1 的表达上调进一步表明 Wnt 信号通路的激活。FMT 后致病性细菌的丰度增加,而产生 SCFA 的细菌和 SCFA 的产生减少。

解释

CRC 患者的肠道微生物群破坏了肠道屏障,诱导了低度炎症和菌群失调。改变的肠道微生物群增强了 Apc 小鼠肠腺瘤的进展,表明针对 CRC 靶向肠道微生物群的新策略值得注意。

基金

本研究得到了国家自然科学基金、天津市应用基础与前沿技术研究计划和中国博士后科学基金的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/019eb8d7f8a7/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/251ef12ee2c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/f817047dc02b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/87340733a14c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/28ae01f7ba13/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/7e09d18f4a50/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/9d039daf7f56/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/f28b9e9449c8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/019eb8d7f8a7/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/251ef12ee2c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/f817047dc02b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/87340733a14c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/28ae01f7ba13/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/7e09d18f4a50/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/9d039daf7f56/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/f28b9e9449c8/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1669/6838415/019eb8d7f8a7/gr8.jpg

相似文献

1
Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apc mice.结直肠癌患者的肠道微生物群可增强 Apc 小鼠肠道腺瘤的进展。
EBioMedicine. 2019 Oct;48:301-315. doi: 10.1016/j.ebiom.2019.09.021. Epub 2019 Oct 5.
2
Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice.肥胖症患者肠道微生物菌群的改变可促进小鼠结直肠肿瘤的发生。
EBioMedicine. 2023 Jul;93:104670. doi: 10.1016/j.ebiom.2023.104670. Epub 2023 Jun 19.
3
YYFZBJS ameliorates colorectal cancer progression in Apc mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.YYFZBJS 通过重塑肠道微生物群和抑制调节性 T 细胞生成来改善 Apc 小鼠的结直肠癌进展。
Cell Commun Signal. 2020 Jul 16;18(1):113. doi: 10.1186/s12964-020-00596-9.
4
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.果胶补充剂显著增强了用来自结直肠癌患者的肠道微生物群人源化的荷瘤小鼠的抗PD-1疗效。
Theranostics. 2021 Feb 19;11(9):4155-4170. doi: 10.7150/thno.54476. eCollection 2021.
5
Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.经口灌胃结直肠癌患者粪便样本可促进无菌和普通小鼠的肠道肿瘤发生。
Gastroenterology. 2017 Dec;153(6):1621-1633.e6. doi: 10.1053/j.gastro.2017.08.022. Epub 2017 Aug 18.
6
Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.胆汁酸与肠道微生物群的相互作用促进了肠道肿瘤的发生。
Mol Carcinog. 2019 Jul;58(7):1155-1167. doi: 10.1002/mc.22999. Epub 2019 Mar 3.
7
Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota.丁酸梭菌是一种产生丁酸的益生菌,通过调节 Wnt 信号通路和肠道微生物群来抑制肠道肿瘤的发展。
Cancer Lett. 2020 Jan 28;469:456-467. doi: 10.1016/j.canlet.2019.11.019. Epub 2019 Nov 14.
8
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.TRIB3 通过与β-catenin 和 TCF4 相互作用来增加结直肠癌细胞干细胞的干细胞特征和肿瘤发生。
Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.
9
Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer.结直肠癌患者的肠道微生物群、短链脂肪酸和粪便 pH 的变化。
Dig Dis Sci. 2013 Jun;58(6):1717-26. doi: 10.1007/s10620-012-2526-4. Epub 2013 Jan 11.
10
Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling.微生物代谢产物三甲胺 N-氧化物通过抑制法尼醇 X 受体信号通路诱导肠道肿瘤发生。
Cell Oncol (Dordr). 2024 Aug;47(4):1183-1199. doi: 10.1007/s13402-024-00920-2. Epub 2024 Feb 5.

引用本文的文献

1
From gut to proteomics: the impact of on post-translational modifications in colorectal cancer.从肠道到蛋白质组学:[具体因素]对结直肠癌翻译后修饰的影响。 (原文中“the impact of ”部分缺失具体内容)
Front Oncol. 2025 Aug 18;15:1599183. doi: 10.3389/fonc.2025.1599183. eCollection 2025.
2
Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3.致瘤性病理共生大肠杆菌LI60C3的表型特征及全基因组分析
Gut Pathog. 2025 Aug 20;17(1):63. doi: 10.1186/s13099-025-00732-1.
3
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer.

本文引用的文献

1
Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.具核梭杆菌——共生菌、机会致病菌和致癌菌。
Nat Rev Microbiol. 2019 Mar;17(3):156-166. doi: 10.1038/s41579-018-0129-6.
2
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.结直肠癌中的肠真菌微生物失调和生态改变。
Gut. 2019 Apr;68(4):654-662. doi: 10.1136/gutjnl-2018-317178. Epub 2018 Nov 24.
3
Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
弗氏柠檬酸杆菌对结直肠癌中NINJ2表达及奥沙利铂耐药性的影响
Cancer Med. 2025 Jul;14(13):e70940. doi: 10.1002/cam4.70940.
4
The antimicrobial metabolite nisin Z reduces intestinal tumorigenesis and modulates the cecal microbiome in Apc mice.抗菌代谢产物乳酸链球菌素Z可减少Apc小鼠的肠道肿瘤发生并调节盲肠微生物群。
bioRxiv. 2025 May 19:2025.05.18.654755. doi: 10.1101/2025.05.18.654755.
5
Tumor-infiltrating immune cell signature score reveals prognostic biomarkers and therapeutic targets for colorectal cancer.肿瘤浸润免疫细胞特征评分揭示了结直肠癌的预后生物标志物和治疗靶点。
Front Immunol. 2025 May 14;16:1583327. doi: 10.3389/fimmu.2025.1583327. eCollection 2025.
6
Gut microbiota and gastrointestinal tumors: insights from a bibliometric analysis.肠道微生物群与胃肠道肿瘤:文献计量分析的见解
Front Microbiol. 2025 Apr 8;16:1558490. doi: 10.3389/fmicb.2025.1558490. eCollection 2025.
7
Initial gut microbiota composition is a determining factor in the promotion of colorectal cancer by oral iron supplementation: evidence from a murine model.初始肠道微生物群组成是口服铁补充剂促进结直肠癌的决定因素:来自小鼠模型的证据。
Microbiome. 2025 Apr 21;13(1):100. doi: 10.1186/s40168-025-02101-1.
8
Genetics, genomics and clinical features of adenomatous polyposis.腺瘤性息肉病的遗传学、基因组学及临床特征
Fam Cancer. 2025 Apr 16;24(2):38. doi: 10.1007/s10689-025-00460-0.
9
Baseline abundance of Akkermansia muciniphila and Bacteroides acidifaciens in a healthy state predicts inflammation associated tumorigenesis in the AOM/DSS mouse model.健康状态下阿克曼氏黏液菌和嗜酸拟杆菌的基线丰度可预测AOM/DSS小鼠模型中与炎症相关的肿瘤发生。
Sci Rep. 2025 Apr 10;15(1):12241. doi: 10.1038/s41598-025-96514-5.
10
Protective Effect of Ganjang, a Traditional Fermented Soy Sauce, on Colitis-Associated Colorectal Cancer in Mice.传统发酵酱油甘酱对小鼠结肠炎相关结直肠癌的保护作用
Foods. 2025 Feb 13;14(4):632. doi: 10.3390/foods14040632.
不同的微生物、代谢物和生态系统定义了缺陷型和 proficient 型错配修复结直肠肿瘤中的微生物组。
Genome Med. 2018 Oct 31;10(1):78. doi: 10.1186/s13073-018-0586-6.
4
Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?肠道生物膜:健康与受损肠道之间的 tipping points?
Trends Microbiol. 2019 Jan;27(1):17-25. doi: 10.1016/j.tim.2018.08.009. Epub 2018 Sep 12.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.通过恢复肠道微生物群产生的正戊酸盐来抑制艰难梭菌的生长。
Gastroenterology. 2018 Nov;155(5):1495-1507.e15. doi: 10.1053/j.gastro.2018.07.014. Epub 2018 Jul 17.
7
Patients with colorectal cancer have identical strains of in their colorectal cancer and oral cavity.结直肠癌患者的结直肠癌组织和口腔中存在相同的菌株。
Gut. 2019 Jul;68(7):1335-1337. doi: 10.1136/gutjnl-2018-316661. Epub 2018 Jun 22.
8
Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment.结直肠癌的突变特征与肿瘤微环境中的特定微生物群落相关。
PLoS Genet. 2018 Jun 20;14(6):e1007376. doi: 10.1371/journal.pgen.1007376. eCollection 2018 Jun.
9
The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get.饮食、肠道微生物群与结直肠癌的关联:我们所吃的可能暗示着我们所得到的。
Protein Cell. 2018 May;9(5):474-487. doi: 10.1007/s13238-018-0543-6. Epub 2018 Apr 30.
10
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.肠道微生物组对癌症、免疫和癌症免疫治疗的影响。
Cancer Cell. 2018 Apr 9;33(4):570-580. doi: 10.1016/j.ccell.2018.03.015.